Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Hardware Technology & Equipment | Small Cap
Health Score : 7.25Aprameya Engineering Ltd demonstrates a mixed financial performance. The company shows strong solvency, growth, and profitability, indicating a solid foundation and effective management in these areas. Efficiency metrics are varied, with excellent fixed asset and inventory turnover balanced by concerning receivable and capital turnover ratios. Liquidity is adequate, though reliance on quick assets over cash is evident. Coverage ratios present a mixed picture, with strong interest coverage offset by the absence of equity dividend coverage. Financial ratios suggest areas needing attention, particularly in earnings per share and book value. Overall, Aprameya Engineering displays considerable strengths but also faces specific challenges that need to be addressed for sustained financial health.
Health Score : 7.25Aprameya Engineering Ltd demonstrates a mixed financial performance. The company shows strong solvency, growth, and profitability, indicating a solid foundation and effective management in these areas. Efficiency metrics are varied, with excellent fixed asset and inventory turnover balanced by concerning receivable and capital turnover ratios. Liquidity is adequate, though reliance on quick assets over cash is evident. Coverage ratios present a mixed picture, with strong interest coverage offset by the absence of equity dividend coverage. Financial ratios suggest areas needing attention, particularly in earnings per share and book value. Overall, Aprameya Engineering displays considerable strengths but also faces specific challenges that need to be addressed for sustained financial health.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
47.77
Industry Median
47.24
Small Cap Median
47.24
P/E RATIO
47.24
P/B RATIO
3.48
Industry Median
2.89
Small Cap Median
2.89
P/S RATIO
4.48
Industry Median
4.33
Small Cap Median
4.33
Others
PEG RATIO
0.00
EV/EBITDA RATIO
22.02
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹126.6 as on Sep 1, 2026.
Growth Score : 10.00The company exhibits strong growth across all key metrics. Very high revenue growth, operating profit growth, EPS growth, asset growth, and net income growth signify robust expansion and improved profitability. This indicates the company is successfully scaling its operations and effectively managing its resources to drive growth. Investor confidence is likely to be high due to the company's demonstrated ability to increase revenues and profits, and it is well-positioned for continued success.
Revenue Growth RateExcellentOperating Profit Growth RateExcellentEarnings Per Share (EPS) GrowthExcellentAsset Growth RateExcellentNet Income Growth RateExcellent| Growth Ratios | Mar 2026 |
|---|---|
| Revenue Growth Rate | -59.38 |
| Operating Profit Growth Rate | -56.84 |
| Earnings Per Share (EPS) Growth | -68.36 |
| Asset Growth Rate | -42.85 |
| Net Income Growth Rate | -68.18 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Aprameya Engineering Ltd | 7.25 | 47.24 | Neutral | 10.53 | 2.65 | 5.13 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
Concall Report⬤13th May 25
H2 & FY25 Earnings Conference Call
NEUTRAL SENTIMENT
Aprameya Engineering Ltd., formerly Transgene Biotek Ltd., is an Indian company primarily engaged in diversified trading activities. It focuses on sourcing and distributing a range of products including medical equipment, industrial goods, and general commodities. The company recently pivoted its business strategy from biotechnology to a trading-centric model.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Aprameya Engineering Ltd's P/E ratio (TTM) is 47.77, compared to the industry median of 47.24 and large cap median of 47.24.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Aprameya Engineering Ltd's P/B ratio is 3.48, compared to the industry median of 2.89 and large cap median of 2.89.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Aprameya Engineering Ltd's P/S ratio is 4.48, compared to the industry median of 4.33 and large cap median of 4.33.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Aprameya Engineering Ltd's PEG ratio is 1.30.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Aprameya Engineering Ltd's EV/EBITDA ratio is 22.02.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Aprameya Engineering Ltd's ROE is 7.39%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Aprameya Engineering Ltd's ROA is 12.80%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Aprameya Engineering Ltd's ROCE is 12.76%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Aprameya Engineering Ltd's operating margin is 19.10%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Aprameya Engineering Ltd's net margin is 9.31%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Aprameya Engineering Ltd's current ratio is 7.30.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Aprameya Engineering Ltd's debt-to-equity ratio is 0.03.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Aprameya Engineering Ltd's interest coverage ratio is 3.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Aprameya Engineering Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Aprameya Engineering Ltd's EPS is -68.36.
(Source line: "Ratios as of 23 Oct 2026, based on last traded price of ₹126.60. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1993 (as Transgene Biotek Ltd.)
Headquarters: Hyderabad, Telangana
Core Offerings: Trading of medical equipment, industrial products, general commodities
Stock Listing: NSE (APRAMEYA), BSE ({bse})
Promoter: S.M.R.K. Raju Group
Incorporated in 1993 as Transgene Biotek Ltd., the company initially focused on biotechnology and pharmaceutical research. Over the years, it faced operational challenges in the biotech sector. In recent years (around 2022-2023), Aprameya Engineering underwent a significant strategic shift, diversifying its business to focus on trading various industrial products, medical equipment, and general commodities. The company was subsequently renamed Aprameya Engineering Ltd. in August 2023 to reflect its new business direction and broader operational scope.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Trading Activities | 100% | Operating Profit |
Trading Activities: Aprameya Engineering Ltd. is primarily engaged in the trading and distribution of a diverse range of products.
Product Portfolio: This includes various types of medical equipment and supplies, industrial goods, and other general commodities.
Business Model: The company leverages its network for sourcing and supplying products, aiming to capitalize on market demand and supply chain efficiencies.
Mr. S.M.R.K. Raju: Chairman & Managing Director. He is a key promoter and leader, steering the company's recent strategic shift into diversified trading activities. Mr. P.R.K. Raju: Chief Financial Officer. Responsible for the financial management and reporting of the company.
No major subsidiaries reported.
Name change from Transgene Biotek Ltd. to Aprameya Engineering Ltd. effective August 2023, reflecting a strategic pivot from biotechnology to diversified trading activities.
The Aprameya Engineering Ltd share price today is ₹126.60 on NSE (APRAMEYA), as of 24 Oct 2026.
As of 23 Oct 2026, Aprameya Engineering Ltd share price is ₹126.60, with previous close ₹126.60. Today's range is ₹126.60 to ₹126.60. The 52-week range is ₹75 to ₹329.
As of today, Aprameya Engineering Ltd's market cap is ₹246.87 crore (Small Cap).
Aprameya Engineering Ltd's current P/E ratio is 47.77, compared to the HARDWARE TECHNOLOGY & EQUIPMENT sector average of 30.
Aprameya Engineering Ltd's current P/B ratio is 3.48.
Aprameya Engineering Ltd's current dividend yield is N/A. Last dividend of ₹0.00 per share was declared on N/A.
Aprameya Engineering Ltd's EPS (TTM) is ₹-68.36.
Aprameya Engineering Ltd., formerly Transgene Biotek Ltd., is an Indian company primarily engaged in diversified trading activities. It focuses on sourcing and distributing a range of products including medical equipment, industrial goods, and general commodities. The company recently pivoted its business strategy from biotechnology to a trading-centric model.
Aprameya Engineering Ltd is promoted by S.M.R.K. Raju Group, holding 74.05% as of 23 Oct 2026.
Aprameya Engineering Ltd is listed on NSE (APRAMEYA) and BSE ({bse}). Its next quarterly results are expected on August 2024.
Adjusted Earnings Per Share (Adjusted EPS)
Financial Performance & Growth
